TY - JOUR
T1 - Prevention of perinatal transmission of hepatitis b virus
T2 - The sensitivity, specificity, and predictive value of the recommended screening questions to detect high-risk women in an obstetric population
AU - Mcquillan, Geraldine M.
AU - Townsend, Timothy R.
AU - Johannes, Catherine B.
AU - Dillard, Todd
AU - Molteni, Richard A.
AU - Ness, Paul M.
AU - Niebyl, Jennifer R.
PY - 1987/9
Y1 - 1987/9
N2 - McQuillan, G. M. (Dept. of Hospital Epidemiology, Johns Hopkins Hospital, Baltimore, MD 21205), T. R. Townsend, C. B. Johannes, T. Dillard, R. A. Molteni, P. M. Ness, and J. R. Niebyl. Prevention of perinatal transmission of hepatitis B virus: the sensitivity, specificity, and predictive value of the recommended screening questions to detect high-risk women in an obstetric population. Am J Epidemiol 1987; 126:484-91.The Advisory Committee on Immunization Practices recommends that all pregnant women be questioned concerning risk factors for hepatitis B virus infection and that those giving positive responses be serotested. The sensitivity, specificity, and predictive value of those recommended questions among 692 parturient women were determined. A total of 59 currently or previously infected women (hepatitis B surface antigen (HBsAg), antibody to hepatitis B surface antigen (anti-HB5), or antibody to hepatitis B core antigen (anti-HBc) seropositive) were compared with the 633 seronegative women. Among nonwhite women, the sensitivity of a positive response to any one of the recommended questions was 60%. Specificity and positive predictive value were 71% and 19%, respectively. Among white women, the sensitivity, specificity, and positive predictive value were 56%, 75%, and 11%, respectively. To increase such unacceptably low sensitivity, the authors included two additional questions: single marital status and Medicaid/medical assistance payer status. Sensitivity increased to 96% among nonwhite women and 84% among white women. However, a positive response to at least one of the recommended questions or to additional questions was elicited from 78% of all women (92% nonwhite and 64% white). The authors conclude that to prevent perinatal transmission of hepatitis B, we must serotest all women in our obstetric population.
AB - McQuillan, G. M. (Dept. of Hospital Epidemiology, Johns Hopkins Hospital, Baltimore, MD 21205), T. R. Townsend, C. B. Johannes, T. Dillard, R. A. Molteni, P. M. Ness, and J. R. Niebyl. Prevention of perinatal transmission of hepatitis B virus: the sensitivity, specificity, and predictive value of the recommended screening questions to detect high-risk women in an obstetric population. Am J Epidemiol 1987; 126:484-91.The Advisory Committee on Immunization Practices recommends that all pregnant women be questioned concerning risk factors for hepatitis B virus infection and that those giving positive responses be serotested. The sensitivity, specificity, and predictive value of those recommended questions among 692 parturient women were determined. A total of 59 currently or previously infected women (hepatitis B surface antigen (HBsAg), antibody to hepatitis B surface antigen (anti-HB5), or antibody to hepatitis B core antigen (anti-HBc) seropositive) were compared with the 633 seronegative women. Among nonwhite women, the sensitivity of a positive response to any one of the recommended questions was 60%. Specificity and positive predictive value were 71% and 19%, respectively. Among white women, the sensitivity, specificity, and positive predictive value were 56%, 75%, and 11%, respectively. To increase such unacceptably low sensitivity, the authors included two additional questions: single marital status and Medicaid/medical assistance payer status. Sensitivity increased to 96% among nonwhite women and 84% among white women. However, a positive response to at least one of the recommended questions or to additional questions was elicited from 78% of all women (92% nonwhite and 64% white). The authors conclude that to prevent perinatal transmission of hepatitis B, we must serotest all women in our obstetric population.
KW - Antibodies
KW - Hepatitis B surface antigens
KW - Hepatitis B virus
KW - Obstetrics
UR - http://www.scopus.com/inward/record.url?scp=0023277454&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023277454&partnerID=8YFLogxK
U2 - 10.1093/oxfordjournals.aje.a114680
DO - 10.1093/oxfordjournals.aje.a114680
M3 - Article
C2 - 3618580
AN - SCOPUS:0023277454
SN - 0002-9262
VL - 126
SP - 484
EP - 491
JO - American Journal of Epidemiology
JF - American Journal of Epidemiology
IS - 3
ER -